A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
Clinical trial NCT07228390 · RECRUITING
Trial details
- NCT number
- NCT07228390
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-13
- Primary completion
- 2027-03-05
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.